← Back to Clinical Trials
Recruiting NCT06518889

NCT06518889 Medium to Long Term Outcomes of Selective Dorsal Rhizotomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06518889
Status Recruiting
Phase
Sponsor Great Ormond Street Hospital for Children NHS Foundation Trust
Condition Cerebral Palsy
Study Type OBSERVATIONAL
Enrollment 90 participants
Start Date 2024-06-25
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 90 Years
Study Type OBSERVATIONAL
Interventions
Selective Dorsal Rhizotomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 90 participants in total. It began in 2024-06-25 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The main purpose of this study is to investigate the medium to long-term outcomes (3-10 years) after Selective Dorsal Rhizotomy (SDR) in ambulatory children and young people with cerebral palsy. The participants will complete a survey, come to hospital for some measurements and tests. Some parents and children and young people will also be invited to take part in an interview to understand their experiences of SDR.

Eligibility Criteria

Inclusion Criteria: * Children and young people with cerebral palsy (CYPwCP) * Classified as GMFCS level II and III (ambulatory) * Aged between 2-15 years at the time of surgery * Underwent SDR surgery at Great Ormond Street Hospital for Children (GOSH) (between 2013- 2021) * Had baseline (pre-surgery) assessment and at least one follow-up assessment at 6, 12 or 24 months post-SDR Parents of CYP with CP who have undergone SDR surgery (and meet the above criteria for CYP) Exclusion Criteria: * Children with CP classified as GMFCS level IV, V (non-ambulatory) * Have any unrelated musculoskeletal problems, such as a recent acute injury

Contact & Investigator

Central Contact

Deepti Chugh

✉ deepti.chugh@gosh.nhs.uk

📞 02074059200

Principal Investigator

Eleanor Main

PRINCIPAL INVESTIGATOR

Great Ormond Street Institute of Child Health, University College London

Frequently Asked Questions

Who can join the NCT06518889 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 90 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06518889 currently recruiting?

Yes, NCT06518889 is actively recruiting participants. Contact the research team at deepti.chugh@gosh.nhs.uk for enrollment information.

Where is the NCT06518889 trial being conducted?

This trial is being conducted at London, United Kingdom.

Who is sponsoring the NCT06518889 clinical trial?

NCT06518889 is sponsored by Great Ormond Street Hospital for Children NHS Foundation Trust. The principal investigator is Eleanor Main at Great Ormond Street Institute of Child Health, University College London. The trial plans to enroll 90 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology